Current Issue

Sponsored
Keywords

RNAi/siRNA - Related Content

THIS KEYWORD IS SPONSORED BY:

Feature Articles: Advances in RNAi Tools and Technologies
Tutorials: Overcoming Drawbacks of Gene Silencing with RNAi
Tools for Effective Validation and Utilization
Feature Articles: RNAi’s Enabling Powers
BioPerspectives: How Today's Discoveries Contribute to Tomorrow's Revolution
Expert Tips: 9 Tips for Optimal siRNA Transfection
Transfecting siRNA with a high efficiency won't be a challenge for you anymore thanks to these tips.

Literature Review: Protein—Now You See It, Now You Don't
March 8, 2013
Researchers describe a system for the rapid and complete degradation of proteins in mammalian cells.
With Oligonucleotide Drugs, Antisense Arrives but RNAi Has a Long Way to Go
June 11, 2012
Isis filed an NDA for its HoFH antisense treatment, while Alnylam reported Phase III failure with RSV infection RNAi candidate.
EPO Decision, Utah Litigation Show Tuschl Patents Remain Mired in Litigation
April 5, 2012
Just as the dust settled in Europe regarding Alnylam’s Tuschl I claims, a lawsuit contesting Tuschl II ownership in the U.S. has risen.
Are Early Clinical Successes Enough to Bring RNAi Back from the Brink?
June 15, 2011
While data presented at ASCO is certainly encouraging, there is still some trepidation.

ANTIBIOTICS ENHANCE RNAI CAPABILITIES
- Interview with Peng Jin, Ph.D., Assistant Professor, Department of Human Genetics, Emory University School of Medicine
RNAi TECHNOLOGY
- GEN's Editor-in-Chief John Sterling interviews Richard Jorgensen, Ph.D., from the University of Arizona